跳至主要内容
临床试验/EUCTR2004-001239-42-CZ
EUCTR2004-001239-42-CZ进行中(未招募)不适用

Evaluation of tolerance of preparation KETOPROFEN HBF GEL 2.5% (Herbacos-bofarma) and its comparison with preparation PROFENID GEL (Laboratoires Aventis) in patients with benign joint injury.

RE&D VÚFB, s.r.o.0 个研究点目标入组 100 人开始时间: 2005年6月14日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - adult outpatients
  • - bruised or sprained joint suitable for local antiinflammatory treatment
  • - written informed consent
  • - commitment to respect therapeutic regime
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - patients younger than 18 and older than 75 years
  • - pregnant or nursing women
  • - allergy to components of preparation
  • - rheumatic joint disease
  • - skin infection
  • - skin damage in application site

研究者

发起方
RE&D VÚFB, s.r.o.

相似试验